Reply to Godbole et al

Clin Infect Dis. 2018 Jun 1;66(12):1977-1978. doi: 10.1093/cid/ciy033.

Authors

Stefan Schlabe^{1

2}, Carola-Ellen Kleine^{1

2}, Gunnar T R Hischebeth^{2

3}, Ernst Molitor^{2

3}, Yvonne Pfeifer⁴, Jan-Christian Wasmuth^{1

2}, Ulrich Spengler^{1

2}

Affiliations

¹ Department of Internal Medicine I, University Hospital of Bonn.
² German Center of Infection Research, Partnerside Cologne-Bonn.
³ Institute of Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn.
⁴ FG13 Nosocomial Infectious Agents and Antibiotic Resistance, Robert Koch Institute, Wernigerode, Germany.

PMID: 29471433
DOI: 10.1093/cid/ciy033

No abstract available

Publication types

Comment

MeSH terms

Fluoroquinolones
Fosfomycin*
Meropenem
Salmonella typhi
Serogroup
beta-Lactamases

Substances

Fluoroquinolones
Fosfomycin
beta-Lactamases
Meropenem